Bengaluru, April 3 -- The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent. About 30 percent of Indian Pharmaceutical exports are accounted by US alone.

On 3 April 2025, the US administration announced that it would exempt India's pharma industry from reciprocal tariffs. In this article, we would look at one company which will benefit from recent developments.

Price Movement With a market capitalization of Rs 677 crore, the shares of Medicamen Biotech Ltd made a 52-week high of Rs 630 per share, down by 15 percent from its current market price of Rs 533.30 per share.

About the announcement On 3 April 2025, the company announced that it had signed a co...